Track the PERSONALIS INC share price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was reported on 29 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: AARON TACHIBANA. The full history is openly available.
Analysts rate PERSONALIS INC Buy (bullish), based on 4 analysts. Average price target: US$15.44.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
PERSONALIS INC es una empresa que cotiza en el mercado XNAS, especializada en soluciones genómicas personalizadas. Se enfoca en mejorar la atención médica a través de análisis genéticos avanzados.